Small LIVER Cancer: Practical solutions to speed up care for early hepatocellular cancer
Official title: Small LIVER Cancer: Development of a Multi-Level Intervention to Improve Access to CURE (LIVER:CURE)
Funded at Albert Einstein College of Medicine · NIH-11300179 · Data updated 2026-11-12
A clinician-investigator is being trained to find real-world ways to help people with small liver cancer get guideline-concordant treatment more quickly.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project start | March 10, 2025 |
| Project end | July 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $173,904 |
| NIH project number | 5K08CA286847-03 |
| Project ID | NIH-11300179 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with small hepatocellular carcinoma who are navigating the treatment pathway.
✕Less likely to help
Patients not facing delays in treatment or not represented in care-delivery disparities may see limited direct benefit.
What this research studies
This grant supports Dr. Resmi Charalel as she builds skills to identify barriers and facilitators in the care pathway for small hepatocellular carcinoma and to test practical interventions that shorten the time from diagnosis to treatment. The training covers qualitative research, healthcare delivery science, and implementation science, with the goal of delivering timely, guideline-based care for small HCC. The work will involve stakeholder engagement to design and pilot interventions that improve access and utilization of appropriate therapies. The overall aim is to empower patients by reducing disparities in care delivery for this cancer.
Why it matters
Potential benefit: If successful, patients with small HCC could receive timely, guideline-based treatment more consistently.
How similar studies have gone: There is evidence that addressing care-delivery barriers can improve treatment timeliness in cancer, but this project focuses on implementing practical, stakeholder-driven solutions for small HCC.
Where this research is happening
-
Albert Einstein College of Medicine
Bronx, United States Active
Researchers
- Principal investigator: Charalel, Resmi — Albert Einstein College of Medicine
- Study coordinator: Charalel, Resmi
Related research
Other NIH-funded projects on the same topics.
-
AI-powered liver cancer screening using ultrasound blood flow patterns
A new AI-based method analyzes liver blood flow signals to help detect liver cancer early in people with liver disease, especially in settings with limited resources.
-
Aging and liver cancer: new ways to prevent and fight hepatocellular carcinoma
This research explores how aging promotes liver cancer and tests new preventive approaches that could help people at higher risk due to age.
-
Testing new therapies for pediatric and young adult sarcoma, kidney, and liver cancers
Researchers are testing new drugs and smart combinations in models of pediatric cancers to help guide future treatments for kids and young adults.
-
Liver cancer prevention and care in Uganda using HIV clinic networks
A program in Uganda uses existing HIV care systems to roll out liver cancer prevention, screening, and treatment strategies tailored to local needs.
-
Leveraging HIV care to prevent liver cancer in Uganda
A program in Uganda uses existing HIV care clinics to roll out a liver cancer prevention and treatment plan tailored to local needs.
-
Damaged telomeres and telomerase in liver scarring and liver cancer
Using human stem-cell models, researchers look at how short telomeres and telomerase changes can lead to liver scarring and liver cancer for people with telomere-related risks.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.